<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03302871</url>
  </required_header>
  <id_info>
    <org_study_id>KOUKAEK 2016/20</org_study_id>
    <nct_id>NCT03302871</nct_id>
  </id_info>
  <brief_title>Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-A</brief_title>
  <official_title>Integrated Management With Brain Stimulation and Hybrid Training Enhances Functional Gains in Children With Cerebral Palsy Treated by Botulinum Toxin A</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evidence from literature support the use of Botulinum toxin A (BoNT-A) for upper limb
      spasticity management in children with cerebral palsy (CP). Constraint Induced Movement
      Therapy (CIMT) and Bilateral Intensive Training (BIT) are indicated as effective and
      complimentary treatments to improve motor function in these children. In a recent trial
      combined noninvasiv brain stimulation and CIMT enhanced therapy induced functional gains.

      In this clinical trial the aim was to evaluate the effects of transcranial direct current
      stimulation (t-DCS) plus intensive hybrid training model of modified CIMT and BIT when
      integrated with BoNT-A treatment in children with unilateral CP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although BoNT-A is effective in spasticity management there is inconclusive evidence to
      support its usage for improvement in upper limb activity and function. Combination of BoNT-A
      and occupational therapy (OT) is found to be more effective then OT alone in reducing
      impairment, improving activity level and goal achievement. Intensive hybrid training models
      of CIMT and BIT and noninvasive brain stimulation are promising treatments on motor learning
      in children with CP. The aim of this clinical trial is to show the additional gains that
      could be provided by an integrated treatment of transcranial direct current stimulation
      (t-DCS) plus intensive hybrid training model of modified CIMT and BIT to BoNT-A injections in
      children with unilateral CP.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2016</start_date>
  <completion_date type="Anticipated">December 18, 2017</completion_date>
  <primary_completion_date type="Anticipated">November 18, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assisting Hand Assesment</measure>
    <time_frame>6 weeks</time_frame>
    <description>Bilateral Hand Function Evaluation Instrument</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Jebsen Taylor Hand Function Test</measure>
    <time_frame>6 weeks</time_frame>
    <description>Unilateral Hand Function Evaluation Instrument</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Modifed Ashworth Scale</measure>
    <time_frame>6 weeks</time_frame>
    <description>Measurement of Tone</description>
  </other_outcome>
  <other_outcome>
    <measure>Active ROM of wrist dorsiflexion</measure>
    <time_frame>6 weeks</time_frame>
    <description>Measurement of active muscle function</description>
  </other_outcome>
  <other_outcome>
    <measure>Modified Tardieu Scale</measure>
    <time_frame>6 weeks</time_frame>
    <description>Measurement of spasticity</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>İntensive Therapy Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children who received Botulinum toxin type A to plegic upper limb would be treated by transcranial direct current stimulation and a hybrid training model of CIMT and BIT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children who received Botulinum toxin type A to plegic upper limb would continue their usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin type A</intervention_name>
    <arm_group_label>İntensive Therapy Group</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>Botox, Dysport</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <arm_group_label>İntensive Therapy Group</arm_group_label>
    <other_name>noninvasiv brain stimulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hybrid training model of CIMT and BIT</intervention_name>
    <arm_group_label>İntensive Therapy Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual care</intervention_name>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>physical therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of unilateral cerebral palsy

          -  able to activate wrist and finger flexors

          -  being scheduled for BoNT-A treatment for upper limb

        Exclusion Criteria:

          -  significant loss of wrist and or fingers

          -  history of orthopedic surgery to plegic upper limb
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nigar Dursun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kocaeli University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nigar Dursun, MD</last_name>
    <phone>905334322568</phone>
    <email>nigard@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cigdem Cekmece, PhD</last_name>
    <phone>905335483955</phone>
    <email>cigdemcekmece@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kocaeli University</name>
      <address>
        <city>Kocaeli</city>
        <zip>41050</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nigar Dursun, MD</last_name>
      <phone>905334322568</phone>
      <email>nigard@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Cigdem Cekmece, PhD</last_name>
      <phone>905335483955</phone>
      <email>cigdemcekmece@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Begum C Tayyare, PHD student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2017</study_first_submitted>
  <study_first_submitted_qc>October 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2017</study_first_posted>
  <last_update_submitted>October 5, 2017</last_update_submitted>
  <last_update_submitted_qc>October 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli University</investigator_affiliation>
    <investigator_full_name>Nigar Dursun</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <keyword>cerebral palsy</keyword>
  <keyword>botulinum toxin A</keyword>
  <keyword>constraint induced movement therapy</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

